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Reactivation of IgG-switched memory B cells by
BCR-intrinsic signal ampliﬁcation promotes IgG
antibody production
Johannes Lutz1, Kai Dittmann1, Michael R. Bo¨sl2,w, Thomas H. Winkler3, Ju¨rgen Wienands1 & Niklas Engels1
Secondary antibody responses are marked by faster kinetics, improved antibody afﬁnity and a
switch from IgM to other immunoglobulin isotypes, most notably IgG, compared with primary
responses. These changes protect from reinfection and represent the principle of most
vaccination strategies. Yet, the molecular mechanisms that underlie B-cell memory responses
are unclear. Here we show, by inactivating the immunoglobulin tail tyrosine (ITT) signalling
motif of membrane-bound IgG1 in the mouse, that the ITT facilitates maintenance and
reactivation of IgG-switched memory B cells in vivo. The ITTmotif equips IgG-switched cells
with enhanced BCR signalling capacity, which supports their competitiveness in secondary
immune reactions and drives the formation of IgG-secreting plasma cells even in the absence
of T-cell help. Our results demonstrate that ITT signalling promotes the vigorous production
of IgG antibodies and thus provide a molecular basis for humoral immunological memory.
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T
he production of antibodies by B lymphocytes is initiated
on recognition of extracellular antigen by clonotypic
antigen receptors expressed on the B-cell surface. On
secondary antigen encounter, antibody responses are more
vigorous and dominated by the production of immunoglobulin
G (IgG) antibodies. However, the mechanisms that encode such
improved memory responses remain unclear. Binding of antigen
to B-cell antigen receptors (BCRs) initiates a complex series of
signalling events that, in combination with costimulatory signals,
promote cellular activation and differentiation into antibody-
producing plasma cells1. A monomeric BCR unit is composed of
a membrane-bound immunoglobulin (mIg) molecule of one of
the ﬁve classes, mm, dm, gm, em, or am, that non-covalently
associates in a 1:1 stoichiometry with a heterodimer of mIg-
associated a and b proteins (Iga/b, CD79a/b) on the cell
surface2,3. Antigen-mediated reorganization of BCR complexes
triggers the activation of cytoplasmic protein tyrosine kinases
(PTKs) that phosphorylate immunoreceptor tyrosine-based
activation motifs (ITAMs) in the cytoplasmic domains of Iga
and Igb (refs 4–7). Phosphorylated ITAM tyrosines serve as
docking sites as well as allosteric activators for PTKs of the spleen
tyrosine kinase (Syk) family8,9. In addition, Iga contains an
evolutionary conserved non-ITAM tyrosine residue (Y204) that
on phosphorylation recruits the central adaptor protein
Src-homology 2 (SH2) domain containing adaptor protein of
65 kDa (SLP65, also called BLNK) via its SH2 domain10.
Syk-mediated phosphorylation of SLP65 then enables the
formation of a supramolecular signalling platform from which
the activation of ubiquitous signalling cascades is initiated11.
The importance of individual ITAM and non-ITAM tyrosine
residues in Iga and Igb for the development of the B-cell
compartment and antibody production has been analysed in a set
of mouse strains expressing tyrosine-to-phenylalanine (YF) mutant
versions of Iga or tyrosine-to-alanine mutant Igb (refs 12–14).
Inactivation of either ITAM motif alone has little impact on B-cell
development and overall antibody production. Combined
inactivation of both BCR ITAMs, however, causes an almost
complete block in B-cell development at the proB- to preB-cell
transition13. The SLP65-binding non-ITAM tyrosine motif in Iga
is dispensable for the development of B2 B cells but has a speciﬁc
function in supporting T-independent antibody responses14.
Immunization with T-dependent antigens initiates the
formation of germinal centres in which activated B cells
can undergo afﬁnity maturation and immunoglobulin class
switching. The cellular outputs of germinal centres are
antibody-secreting plasma cells and memory B cells that are
poised to differentiate into plasma cells on antigen reencounter15.
Immunoglobulin class-switch recombination to IgG or IgE
isotypes equips B cells with altered BCRs that in addition
to the canonical Iga/b signalling subunit contain signalling
motifs in the cytoplasmic domains of the respective mIg
heavy chains, which are absent in mIgM- and mIgD-BCRs
of naive cells. On antigen binding, these immunoglobulin
tail tyrosine (ITT) motifs become phosphorylated and
serve as docking sites for the ubiquitous cytoplasmic
adaptor protein growth factor receptor-bound 2 (Grb2).
Recruitment of Grb2 and its binding partner Bruton’s tyrosine
kinase (Btk) into the signalosome of mIgG- and mIgE-containing
BCRs ampliﬁes BCR-proximal signalling events, including
phosphorylation of SLP65 and subsequent Ca2þ
mobilization16–18. The essential importance of the entire
cytoplasmic domains of mIgG and mIgE for antibody responses
of the respective isotype was demonstrated in genetically
engineered mouse models19–21. Whether or not the ITT motif
is responsible for the function of the cytoplasmic tails of mIgG
and mIgE in vivo, remained, however, unknown.
Here we demonstrate that inactivation of the ITT by a YF
substitution in mIgG1 leads to substantially impaired IgG1
antibody responses in the mouse. This is due to the reduced
generation of IgG1-secreting plasma cells despite normal memory
cell formation. In heterozygous animals, cells expressing YF-
mutant mIgG1 have a strong competitive disadvantage in
entering the plasma cell compartment compared with cells
expressing wild-type mIgG1. Furthermore, the ITT improves the
reactivation of memory B cells in a T-cell-independent manner.
Our results show that ITT signalling is essential for B-cell
memory in vivo.
Results
ITT phosphorylation enhances BCR-proximal signalling. To
investigate the function of the ITT signalling motif in vivo, we
introduced a point mutation into the genome of C57BL/6 mice
that causes a YF substitution in the cytoplasmic domain of mIgG1
(mIgG1-YF; for details see Supplementary Figs 1 and 2). First, we
compared the signalling capabilities of YF-mutant and wild-type
mIgG1-BCRs in primary cells and used phosphorylation of the
adaptor protein SLP65 and the serine/threonine kinase v-akt
murine thymoma viral oncogene homologue 1 (Akt, also called
protein kinase B, PKB) as readouts for the activation of BCR-
regulated signalling pathways (Fig. 1a,b, respectively, and
Supplementary Fig. 3A). In line with our previous observations in
transfected B cells16,17 inactivation of the ITT caused a substantial
reduction in phosphorylation of SLP65 under optimal and
suboptimal stimulation conditions (Fig. 1a). By contrast, the
activation of Akt was not affected by the ITT mutation (Fig. 1b),
showing that the ITT speciﬁcally improves the activation of
Ca2þ -regulating components in IgG-switched cells. As control,
splenic B cells of both genotypes were treated with F(ab’)2
fragments to IgM, which demonstrated their equal signalling
capacities (Supplementary Fig. 3B). Next, we tested whether the
enhanced phosphorylation of SLP65 was associated with
augmented Ca2þ mobilization in IgG1-switched B cells. To this
end, puriﬁed splenic B cells from immunized mice were loaded
with Indo-1 and stained with FITC-conjugated non-activating
monomeric anti-IgG1 Fab fragments. Subsequently, mIgG–BCRs
were stimulated with polyclonal anti-IgG F(ab’)2 fragments. This
setting allowed us to monitor BCR-induced Ca2þ mobilization
selectively in mIgG1-positive cells (Fig. 1c and Supplementary
Fig. 4A). Inactivation of the ITT caused a strong reduction in
BCR-induced Ca2þ mobilization as previously shown in
transfected B cells. As control, splenic B cells of both genotypes
were treated with F(ab’)2 fragments to IgM (Supplementary
Fig. 4B). In conclusion, phosphorylation of the ITT motif greatly
improves mIgG–BCR signalling by promoting BCR-induced
Ca2þ signalling even under conditions of suboptimal
stimulation. This improved reactivity of mIgG–BCRs is brought
about by the recruitment of a Grb2/Btk signalling module to the
ITT motif, which facilitates activation of phospholipase C-g and
subsequent second messenger generation16,17.
Germinal centre B cells do not require ITT signalling.
Membrane-bound IgG-containing BCRs are expressed for the
ﬁrst time in the life of a B cell following successful immunoglo-
bulin class-switch recombination, which predominantly occurs
during germinal centre reactions. To test whether B cells require
ITT signals to prevail in the competitive environment of a
germinal centre, we investigated the cellular composition of
germinal centres in mIgG1-YF mice during a primary immune
response against the hapten 4-hydroxy-3-nitrophenylacetyl (NP)
coupled to the carrier protein keyhole limpet haemocyanin
(KLH). We followed the generation of mIgG1-expressing cells
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during the ﬁrst 15 days of the primary response and used CD38
as a marker to differentiate between memory (CD38-positive)
cells and activated germinal centre (CD38-negative) B cells22
(Supplementary Fig. 5). The kinetics of mIgG1-positive germinal
centre B-cell generation during the primary response was very
similar in mIgG1-YF and wild-type mice, even though there was a
trend towards a somewhat higher production in wild-type mice at
days 11 and 15 (Fig. 2a). Also, mIgG1-expressing cells speciﬁc for
the hapten NP were produced in similar amounts in both
genotypes (Fig. 2b and Supplementary Fig. 6) as were NP-speciﬁc
mIgM-expressing cells (Fig. 2c). Furthermore, we analysed the
generation of antibody-secreting cells during the primary
response to NP–KLH. The numbers of IgG1-secreting cells in
the spleens of both genotypes were comparable during the ﬁrst
9 days of the primary antibody response. After that period the
numbers of IgG1-producing cells in wild-type animals were two-
to threefold higher than in mIgG1-YF animals (Fig. 2d). The
numbers of IgM-secreting cells were the same in both animal
groups throughout the experiment (Fig. 2e). Thus, ITT signalling
does not seem to be a major driving force for the generation of
IgG-switched B cells in the highly selective environment of a
germinal centre but seems to favour the formation of IgG-
secreting cells already in the primary immune response.
The ITT improves the maintenance of IgG-switched B cells.
Even though ITT signals were not essential for the generation of
IgG-switched cells during germinal centre reactions, the possi-
bility remained that their survival in the periphery may be
regulated by the ITT. Hence, to test whether the ITT motif
contributes to the maintenance of memory B cells, we determined
the frequency of NP-speciﬁc mIgG1-positive B cells in the spleens
of wild-type and ITT-mutant mice 11 weeks and 36 weeks after
immunization with NP–KLH (Supplementary Fig. 7). Whereas
the frequency of antigen-speciﬁc mIgG1-expressing cells was
similar in both genotypes 11 weeks after immunization (Fig. 3a),
their number was roughly four times higher in wild-type animals
36 weeks after immunization (Fig. 3b). We conclude that the
presence of intact ITT motifs in the cytoplasmic domains of
membrane-bound IgG molecules improves the lifespan of IgG-
switched memory B cells, presumably by enhanced tonic signal-
ling of ITT-containing mIgG–BCRs23.
ITT signalling promotes production of IgG antibodies. To
investigate the inﬂuence of ITT signals on IgG production, we
analysed the kinetics of IgG1 antibody formation and afﬁnity
maturation against NP in ITT-mutant and wild-type animals.
Total IgG1 antibody titres in mIgG1-YF mice increased much
slower than in wild-type animals (Fig. 4a), and were reduced
approximately by half on day 28 of the primary response
(Fig. 4b). These differences in IgG1 production during the pri-
mary response are consistent with the differences in early plasma
cell formation (Fig. 2d). The isotypes IgG2b and IgG2c were
moderately elevated in the sera of mIgG1-YF mice (Fig. 4c,d)
indicating the existence of compensatory mechanisms as observed
before19. Next, we compared the kinetics of total and high-afﬁnity
NP-speciﬁc IgG1 antibodies in mIgG1-YF and wild-type mice
during primary and secondary immune responses. Note that re-
immunization was done at a time point when numbers of
antigen-speciﬁc mIgG1-positive memory B cells were roughly the
same in both genotypes (Fig. 3a). Again, the production of IgG1
in ITT-mutant mice was strongly diminished compared with
wild-type animals. IgG1 titres during recall responses in mIgG1-
YF animals were reduced to approximately one-third of what we
observed in wild-type controls and thus did not even reach the
level of primary response titres of wild-type mice (Fig. 4e).
Analysis of high-afﬁnity NP-speciﬁc IgG1 antibodies gave similar
results (Fig. 4f). The ratio of high-afﬁnity to total NP-speciﬁc
IgG1 titres was moderately elevated in wild-type animals during
primary responses, yet increased over time in a comparable
manner in both genotypes (Fig. 4g). As control, we determined
the production of high-afﬁnity IgG2c antibodies, which was
similar in both genotypes (Fig. 4h). These results show that
in vivo ITT-induced signals are essential to generate proper IgG
antibody responses.
The ITT improves the competitiveness of IgG-switched cells.
To compare the performance of wild-type and ITT-mutant B cells
directly in the same animals, we bred mIgG1-YF BL/6 mice
expressing ITT-mutant mIgG1b with Balb/c mice expressing
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Figure 1 | The ITT ampliﬁes BCR-induced Ca2þ signalling. Splenic B cells
from naive wild-type (wt) and ITT-mutant (YF) mice were isolated by
magnetic cell sorting and stimulated with either low (2mgml 1, left panels)
or high (10 mgml 1, right panels) doses of anti-IgG F(ab’)2 fragments.
Unstimulated cells served as controls (ﬁlled histograms). Subsequently,
cells were stained with phospho-speciﬁc antibodies to either SLP65 (a) or
Akt (b) wt: (black curves), YF: mIgG1-YF (grey curves). (c) Splenic B cells
from three age-matched male mice of each genotype that had been
immunized with sheep red blood cells for 11 days were pooled, loaded with
Indo-1-AM and stained with FITC-labeled monomeric Fab fragments against
IgG1. Ca2þ mobilization of mIgG1-positive cells was monitored before and
after stimulation with anti-IgG F(ab’)2 fragments (20mgml 1, indicated by
an upward arrow) in the presence of 1mM extracellular CaCl2. Data are
representative of three to four experiments.
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heterozygous F1 animals expressed either wild-type (allotype a)
or YF-mutant (allotype b) mIgG1. Animals that had both allo-
types in wild-type form served as controls. Allotype-speciﬁc
analysis of IgG1 production in animals that were immunized with
ovalbumin (OVA) in aluminium hydroxide (alum) showed that
wild-type mIgG1a-expressing B cells contributed up to six times
more to the production of soluble IgG1 than their mIgG1b-
expressing ITT-mutant counterparts both during primary and
secondary responses (Fig. 5a,c, grey graph). In control animals,
both allotypes of IgG1 were produced in equal amounts (Fig. 5b)
and, hence, were present in an almost 1:1 ratio during the entire
course of the experiment (Fig. 5c, black graph). In conclusion,
these results reveal that ITT-mediated signal ampliﬁcation
increases the competitiveness of mIgG-expressing cells, which
facilitates their contribution to antibody production.
ITT signals promote plasma cell formation. To test whether
reduced antibody production by ITT-mutant B cells was linked to
impaired plasma cell generation, we determined the frequency
of OVA-speciﬁc IgG1 antibody forming cells in heterozygous
F1 animals at day 21 of the recall response by means of
allotype-speciﬁc ELISPOT assays (Fig. 6a). In accordance
with the diminished IgG1b serum titres (Fig. 5) we observed an
approximately fourfold reduction in the number of YF-mutant
IgG1b-producing antibody forming cells compared with IgG1a-
producing cells both in the bone marrow (Fig. 6a,b,d) as well as in
the spleens of heterozygous F1 animals (Fig. 6c,d). We conclude
that ITT signalling supports the generation of plasma cells from
the memory cell compartment.
ITTs promote T-cell-independent activation of memory B cells.
The reactivation requirements of memory B cells, particularly the
need for T-cell help, are not fully understood. However, reacti-
vation of memory B cells by antigen, especially viruses, can occur
independently of T cells24–27, yet seems to require speciﬁc niches
in secondary lymphoid tissue28. To test whether ITT signalling
contributes to the improved reactivation of IgG-switched
memory B cells in the absence of T-cell help, we employed a
cell transfer approach in which wild-type and YF-mutant mIgG1-
expressing memory B cells were transferred into Rag1-deﬁcient
recipient mice. To be able to monitor the responsiveness of
memory B cells expressing other Ig isotypes and to generate a
competitive environment, we transferred total B cells depleted of
T cells. The transferred cells were derived from animals that
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Figure 2 | IgG-switched germinal centre B cells do not require ITT signalling. Cohorts of sex- and age-matched male and female wild-type (wt) and ITT-
mutant (YF) mice were immunized with NP–KLH. (a) Kinetics of germinal centre B-cell generation in the spleen. Relative frequency of B220-positive,
CD38-negative cells among mIgG1-expressing cells during the course of the experiment. (b) NP-speciﬁc splenic B cells were identiﬁed with NP8-PE. The
percentage of NP-binding mIgG1-positive B cells is shown. (c) Kinetics of mIgM-positive, NP-binding splenic B cells. (d,e) The numbers of antibody forming
cells (AFCs) per 106 splenocytes was determined by ELISPOT assays for IgG1 (d) and IgM (e). Numbers of analysed animals are as follows: a,b,c and e
shows mean values±s.e.m. of three independent experiments with three animals per genotype and time point (that is, n¼ 9 per time point and genotype).
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Figure 3 | The ITT improves the maintenance of IgG-switched memory B
cells. (a) Frequencies of mIgG1þ , NP-speciﬁc B cells in spleens of male
wild-type (wt, n¼ 7) and ITT-mutant (YF, n¼6) mice 11 weeks after
immunization with NP–KLH are given as number of cells per 106 B220-
positive cells. (b) Cells were analysed as in a 36 weeks after immunization
(wt: n¼ 6, YF: n¼4). Statistical signiﬁcance was determined by
Mann–Whitney test. NS: not signiﬁcant, *Po0.05, **Po0.01. Immuniz.,
immunization; wks, weeks.
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cytomegalovirus (hCMV) (Fig. 7a) and were adjusted to contain
equal numbers of glycoprotein B-speciﬁc mIgG1-positive
cells (Supplementary Fig. 8). Consistent with our previous
observation (Fig. 3b) the frequency of glycoprotein B-speciﬁc
mIgG1-expressing cells 20 weeks after the last booster
immunization was lower in ITT-mutant mice than in wild-type
animals (Fig. 7b and Supplementary Fig. 8A). Therefore, we
transferred roughly 1.5 times more B cells expressing other Ig
isotypes from mIgG1-YF mice (Supplementary Fig. 8B).
Subsequently, recipient animals were challenged with virus-like
particles that contained glycoprotein B in their envelope, which
triggers memory B-cell reactivation but does not generate a
primary response26. During the entire course of the experiment,
glycoprotein B-speciﬁc IgG1 titres were consistently three times
higher in animals that had received wild-type mIgG1-expressing
B cells than in animals that had received ITT-mutant cells
(Fig. 7c). As experimental control, we measured the simultaneous
production of IgG2c antibodies against glycoprotein B, which was
enhanced in recipients that had received B cells from mIgG1-YF-
mutant mice (Fig. 7d). Since we transferred slightly more cells
from ITT-mutant mice to obtain equal numbers of mIgG1-
expressing cells, the enhanced IgG2c production might be due to
a higher number of transferred IgG2c-positive cells and/or
compensatory mechanisms as observed before (Fig. 3 and19). At
any rate, the results show that ITT-mediated improved
reactivation of mIgG-positive memory B cells occurs also in the
absence of T-cell help and thus is a B-cell-intrinsic feature.
Discussion
Immunoglobulin class-switch recombination alters the molecular
composition of BCRs. While the canonical Iga/b signalling unit
remains unchanged, mIgG- (and mIgE-) BCRs are equipped with
two copies of an additional tyrosine-based signalling motif
referred to as ITT. In this study, we demonstrate that the ITT
is a key determinant of humoral immunological memory in vivo.
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Figure 4 | The ITT promotes IgG antibody production. (a) Wild-type (wt, black line) and homozygous mIgG1-YF (YF, grey line) female animals were
immunized with NP–KLH in aluminium hydroxide and total IgG1 titres were monitored for 28 days. Data are shown as mean±s.e.m. of 5–6 animals per
group. Titres for IgG1 (b), IgG2b (c) and IgG2c (d) of the animals shown in a were determined at day 21 after immunization. Error bars indicate
mean±s.e.m. (e) Wild-type and mIgG1-YF male mice were immunized as in a and boosted 85 days later. The production of total NP-speciﬁc antibodies
was determined using ELISA plates coated with NP14-BSA. Data are shown as mean of 4–5 animals per group±s.e.m. (f) The amount of high-afﬁnity
NP-speciﬁc antibodies in the sera of the animals shown in e were analysed using NP1-BSA-coated ELISA plates. (g) The ratio of high afﬁnity to total
NP-speciﬁc antibodies in the sera from (e,f) are shown as mean±s.e.m. (h) Titres of high-afﬁnity NP-speciﬁc IgG2c antibodies in the same sera as in
e and f are shown as mean±s.e.m. Statistical signiﬁcance was determined by Mann–Whitney test. *Po0.05, **Po0.01. Data are representative of two
independent experiments.
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This provides a molecular explanation for the phenotype of a
number of mouse models in which the entire cytoplasmic tails of
mIgG1 or mIgE were either deleted or transferred to mIgM,
which indicated their importance for the production of IgG and
IgE antibodies19–21. Furthermore, B cells of ‘mIgG1-only’ mice
exhibit enhanced BCR signalling and a prolonged lifespan
compared with mIgM-expressing cells23. Here we show that the
biological activity of cytoplasmic mIgG tails is mainly mediated
by the ITT signalling motif.
Antigen-induced phosphorylation of the ITT creates a docking
site for the versatile adaptor protein Grb2, the recruitment of
which ampliﬁes BCR-proximal signalling events as well as BCR-
induced cell proliferation16,17. Consistently, B-cell-speciﬁc
inactivation of the Grb2 gene in the mouse impairs reactivation
of IgG-switched memory B cells, corroborating the importance of
the ITT–Grb2 interaction for efﬁcient antibody recall
responses17,29. The most salient signalling effect of ITT-
mediated Grb2-recruitment into the BCR signalosome is the
enhanced activation of phospholipase C-g2 (PLC-g2),
concomitant with a greatly prolonged inﬂux of Ca2þ
across the plasma membrane. In line with this, homoeostasis
of B-cell memory relies on the expression of PLC-g2 since
its cell-type-speciﬁc ablation in mIgG1-expressing B cells causes
reduced formation and survival of IgG1-switched memory
B cells30. Furthermore, in B cells the phosphatase calcineurin,
which controls the activation of transcription factor NF-AT,
is speciﬁcally required for terminal differentiation into
plasma cells31. Considering that the activity of calcineurin is
stimulated by Ca2þ /calmodulin it appears possible that
ITT-mediated prolongation of mIgG–BCR-induced Ca2þ
mobilization augments the activity of calcineurin thereby
supporting the differentiation of IgG-switched B cells into
plasma cells.
Plasma cell differentiation is generally considered to be
governed by two antagonizing groups of transcriptional regula-
tors that either maintain the mature B-cell phenotype, such as
Pax5 and Bcl-6, or induce the plasma cell differentiation
programme like Irf4 and Blimp-1 (ref. 32). Expression of either
set represses the other one and elimination of Bcl-6 and Pax5
expression seem prerequisite for plasma cell differentiation to
occur. Signals from the BCR might tip the balance between these
two sets of transcription factors in favour of the plasma cell
differentiation programme in several ways. First, BCR-induced
proteasomal degradation of Bcl-6 has been reported to occur in a
MAP kinase-dependent manner33. Second, in a reciprocal way
expression of Irf4 is induced on BCR stimulation34,35. Third, the
transcription factor Stat3, which acts in concert with Irf4 to
induce expression of Blimp1 (ref. 36), is activated on BCR
stimulation37,38. Thus, ITT-mediated enhanced signalling of
mIgG–BCRs may facilitate degradation of Bcl-6 and/or
inﬂuence the activity of other components that govern plasma
cell differentiation such as Irf4 and Stat3. Consistent with such a
scenario, B-cell-speciﬁc deletion of stat3 results in a selective
deﬁciency of IgG-producing plasma cells despite normal
formation of germinal centres and memory B cells39. Besides
improved BCR signalling, differential gene expression between
memory and naive B cells has been reported and suggested to be
involved in improved reactivation of memory B cells40–43.
Furthermore, it has been proposed recently that the ability of
both mIgM- and mIgG-expressing memory B cells to generate
antibody-secreting cells on antigen challenge is primarily
determined by their maturation stage that is reﬂected by
expression of the cell surface receptors PD-L2 and CD80
(ref. 43). However, this conclusion was based on cell transfer
experiments that did not reﬂect a physiological environment in
which each (memory) B cell has to compete for antigen with
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Figure 5 | The ITT augments the competitiveness of mIgG-expressing B
cells. Heterozygous male animals whose B cells expressed either wild-type
mIgG1a or YF-mutant mIgG1b (grey lines) and control animals expressing
both allotypes in wild-type conﬁguration (black lines) were immunized with
50mg ovalbumin in aluminium hydroxide and were boosted the same way
85 days later. On day 232, mice were challenged with 5 mg OVA (w/o
alum). The production of OVA-speciﬁc IgG1b (a) and IgG1a antibodies (b)
was determined by ELISA. Data are shown as mean±s.e.m. of 4–6 animals
per group. (c) The ratio of IgG1a to IgG1b titres was calculated for each
animal and is depicted as mean±s.e.m. Black line: wt/wt, grey line: wt/YF.
Statistical signiﬁcance was determined by Mann–Whitney test. *Po0.05,
**Po0.01. Data are representative of three independent experiments.
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antibodies as well as with antigen-speciﬁc (memory) B cells of
other Ig isotypes that stem from the primary response44,45. Our
data and that of other groups clearly show that the responsiveness
of memory B cells is under control of the mIg isotype integrated
into the BCR19,21,45,46.
Consistently, previous in vivo studies showed that a cytoplas-
mic mIgG tail improves antigen-dependent as well as antigen-
independent survival of B cells in the mouse21,23. In line with
these earlier observations, inactivation of the ITT compromised
the maintenance of IgG1-switched cells in our experiments. Even
though we cannot say whether this was due to diminished
homoeostatic proliferation, impaired survival or altered migration
of ITT-mutant cells, data from Waismann et al. suggest that an
mIgG cytoplasmic domain improves the survival of B cells in an
antigen-independent manner23. Hence, it appears likely that the
ITT motif not only improves antigen-induced signalling but
probably also antigen-independent tonic signalling of mIgG–
BCRs.
In conclusion, our data show that the persistence and
reactivation of IgG-switched B cells are under the control of the
BCR and its cytoplasmic signalling machinery. The enhanced
activation of this signalling machinery by the ITT may provide a
clue as to why mIgG-expressing memory B cells are preferentially
reactivated over mIgM-expressing cells in secondary immune
responses45,46. Germinal centre-associated events, however, like
generation of mIgG-expressing cells and antibody afﬁnity
maturation occur independently of ITT signals. In agreement
with these ﬁndings, recent studies demonstrated that BCRs of
germinal centre B cells are silenced by high phosphatase activity47
and that it is the effectiveness of antigen presentation to T helper
cells that determines the fate of a B cell in a germinal centre
reaction48–50. These observations may explain the dispensability of
the ITT in germinal centre processes. Nevertheless, the phenotype
of ITT-mutant mice reveals that the BCR on IgG isotype-switched
cells is endowed with the intrinsic ability to promote humoral
immunological memory even in the absence of cognate T-cell help.

























































a b c d
Anti-IgG1a
Anti-IgG1b
Figure 6 | The ITT promotes plasma cell generation. Animals from Fig. 5 were sacriﬁced on day 22 of the recall response and the number of antibody
forming cells (AFCs) was determined by ELISPOT assays. (a) Representative wells of IgG1a-producing (upper photo) and IgG1b-producing (lower photo)
cells from the same ITT-heterozygous animal are shown. Frequencies of AFCs per one million cells from bone marrow (BM; b) and spleens (c) are shown.
(d) The ratio of IgG1a to IgG1b AFCs in the spleens (Sp) and BM was calculated for each animal. Error bars represent mean±s.e.m. of three (wt/wt) and
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Figure 7 | The ITTpromotes T-cell-independent reactivation of IgG-switched memory B cells. (a) Experimental outline. Female wild-type and ITT-mutant
mice (seven animals per genotype) were repeatedly immunized with puriﬁed gB with or without alum as speciﬁed at the indicated time points. Splenocytes
depleted of T cells and puriﬁed with anti-CD19 magnetic beads were adjusted to contain 200 mIgG1-positive, gB-speciﬁc cells and were injected into 10
Rag1-deﬁcient mice. Seven days later recipient animals were challenged with 0.5 mg of gB-containing virus-like particles (VLPs) and sera were collected at
the indicated time points. (b) Frequencies of gB-binding mIgG1-positive B cells in donor mice before transfer. Titres of gB-speciﬁc IgG1 (c) and IgG2c (d) in
sera of Rag1-deﬁcient recipient mice after challenge with VLPs. Statistical signiﬁcance was determined by Mann–Whitney test. *Po0.05, **Po0.01,
***Po0.001. Data are representative of three independent experiments.
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Methods
Mice. mIgG1-YF knock-in mice were established using DNA from a C57BL/6
clone (RP23-331J13), in which the 19th codon of the transmembrane exon M2 of
the g1 immunoglobulin locus was mutated from TAC to TTC causing an amino
acid exchange from Y to F. In addition, a neomycin resistance cassette with
ﬂanking loxP sites was inserted into the EcoRI restriction site between the two
transmembrane exons M1 and M2 of the g1 immunoglobulin locus. The targeting
vector was electroporated into JM8.F6 ES cells (kindly provided by William C.
Skarnes, Wellcome Trust Sanger Institute, Cambridge, UK), and recombinant ES
cells were injected into eight-cell albino outbred embryos to generate chimeric
offspring. After germline transmission, transgenic offspring were bred to EIIa-cre
mice51 to delete the resistance cassette. Mice were held under speciﬁc pathogen-free
conditions in individually ventilated cages and kept on a pure C57BL/6
background. Wild-type C57BL/6 mice used in Figs 2,4 and 7 were purchased from
Charles River (Sulzfeld, Germany). All other mice were bred in house. All animal
experiments were approved by the state ofﬁce for consumer protection and food
safety of Lower Saxony and performed according to institutional and national
guidelines.
Immunizations. Cohorts of 8–12 weeks old age-matched mice were injected
intraperitoneally with 50 mg OVA (Sigma-Aldrich, Taufkirchen, Germany) or 50 mg
NP–KLH (Biosearch Technologies, Novato CA, USA), each with 25 ml Imject Alum
(Thermo Fisher Scientiﬁc, Bonn, Germany), and boosted as indicated.
Adoptive transfer of memory B cells. Transfer was performed as previously
described28. Brieﬂy, mice were immunized twice intraperitoneally with 5 mg
glycoprotein B derived from hCMV (a gift from Sanoﬁ Pasteur, Lyon, France) in
Imject Alum at intervals of 5 weeks and with 5 mg glycoprotein B in PBS
intravenously 5 weeks later and then rested for another 20 weeks. Subsequently,
single-cell suspensions of splenocytes were depleted of T cells by complement lysis,
followed by Ficoll gradient puriﬁcation and enrichment of CD19þ B cells by
magnetic cell sorting (Miltenyi Biotec). For each donor the frequency of
glycoprotein B-speciﬁc IgG1þ memory B cells was determined by FACS, and total
CD19þ B lymphocytes adjusted to contain 200 glycoprotein B-speciﬁc IgG1þ
memory B cells were transferred into one or two Rag1-deﬁcient recipient mice.
One week after transfer, the recipients were boosted with 0.5 mg glycoprotein
B-containing hCMV-dense bodies (virus-like particles) as described by
Weisel et al.28 and bled regularly.
ELISA. Nunc-Immuno MaxiSorp plates were coated over night at 4 C with
either 1mgml 1 OVA (Sigma-Aldrich) or 10 mgml 1 NP1-BSA or NP14-BSA
(selfmade using 4-Hydroxy-3-nitrophenylacetic acid active ester, Biosearch
Technologies) in 50mM carbonate-bicarbonate buffer. Sera were diluted in PBS
with 1% BSA and incubated over night at 4 C. Antigen-speciﬁc antibodies were
detected with goat anti-IgG1-HRP (SouthernBiotech, catalogue no. 1071-05,
dilution 1:1,000) or biotinylated anti-IgG1a (clone 10.9, BD Biosciences (BD)
catalogue no. 553500, dilution 1:1,000) or anti-IgG1b (clone B68-2, BD catalogue
no. 553533, dilution 1:1,000) followed by Neutravidin-HRP (Pierce, catalogue no.
31001, dilution 1:10,000). ELISAs were developed with ABTS (Sigma-Aldrich),
read with PowerWave 340 (BioTek, Bad Friedrichshall, Germany) and analysed
with Gen5 Software (BioTek). Total Ig concentrations were measured with the
Clonotyping System-HRP (SouthernBiotech).
ELISPOT. MultiScreen HTS ﬁlter plates (Millipore) were coated with either OVA
or NP1-BSA, or NP14-BSA according to manufacturer’s instructions. After
incubation with 1–10 105 cells for 4 h, captured antibodies were detected with
the same detection antibodies and same dilutions as described for ELISAs
and visualized with the AEC Chromogen Kit (Sigma-Aldrich). Wells were
photographed with an ImmunoSpot analyzer (Cellular Technology Limited)
and spots were either counted manually or using Bioreader software (BIO-SYS).
Flow cytometry. Single-cell suspensions were prepared from bone marrow and
spleen. Erythrocytes were removed by incubation with 0.15M NH4Cl, 20mM
HEPES for 5min at room temperature. Cells were then incubated with anti-mouse
CD16/CD32 (Fc Block, clone 2.4G2, BD catalogue no. 553142, dilution 1:100) and
stained for 60min on ice with ﬂuorochrome-conjugated mAbs against CD38 (clone
90, PaciﬁcBlue, BioLegend catalogue no. 102720, dilution 1:500), IgG1 (clone A85-1,
FITC, BD catalogue no. 553443, dilution 1:500), B220 (clone RA-3-6B2, PECy7,
BD catalogue no. 552772, dilution 1:500), NP(8)-PE (Biosearch Technologies,
catalogue no. N-5070-1, dilution 1:100) and glycoprotein B-Cy5 (selfmade).
A cocktail of biotinylated antibodies against CD3e (145-2C11, BioLegend catalogue
no. 100304, dilution 1:500), CD49b (DX5, BioLegend catalogue no. 108904,
dilution 1:500), F4/80 (BM8, BioLegend catalogue no. 123106, dilution 1:500),
TER-119 (TER-119, BioLegend catalogue no. 116204, dilution 1:500) and Ly6G/C
(RB6-8C5, BioLegend catalogue no. 108404, dilution 1:500) in combination with
APC-conjugated streptavidin (BD catalogue no. 554067, dilution 1:500) was used
as negative marker. For intracellular phosﬂow stainings splenic B cells were isolated
by magnetic bead cell sorting (B-cell isolation kit, Miltenyi Biotech, order no.
130-090-862) following stimulation of the cells with either anti-IgG or anti-IgM
F(ab’)2 fragments (Jackson Immuno Research, catalogue no. 115-006-071 and
115-006-075, respectively) using the indicated concentrations for 5min at 37 C in
RPMI 1640 without serum. Cells were spun down, resuspended in BD Phosﬂow
Perm/Wash Buffer I (BD) and stained with Alexa Fluor 647-conjugated antibodies
to either phospho-SLP65 (pY84, clone J117-1278, BD catalogue no. 558443,
dilution 1:6) or phospho-Akt (Ser473, clone D9E, BD catalogue no. 560343,
dilution 1:6) and FITC-conjugated anti-IgG1 (clone A85-1, BD catalogue no.
553443, dilution 1:500). Stained cells were examined on a LSRII ﬂow cytometer
(BD Biosciences), and data were analysed with the FlowJo software (Tree Star,
Inc.). Viable lymphocytes were gated as judged by forward/sideward scattering in
all experiments.
Ca2þ measurements. Splenocytes from three age-matched male mice immunized
with sheep red blood cells for 11 days were pooled. B cells were enriched by
magnetic CD43-depletion (Miltenyi Biotech) and stained with rat anti-mouse
IgG1-FITC Fab fragments (clone A85-1, BD catalogue no. 553443). Fab fragments
were generated by papain cleavage using the Pierce Fab Micro Preparation Kit
(Thermo Scientiﬁc) according to the manufacturer’s instructions. Subsequently,
cells were loaded with Indo-1-AM as previously described16. mIgG–BCRs were
stimulated with 20 mgml 1 goat anti-mouse IgG F(ab’)2 fragments (Jackson
Immuno Research). For analysis of mIgG1-expressing cells, FITC-positive cells
were gated.
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